Nexalin Backing Senate Bill to Expand Medicare AI Device Reimbursement
Nexalin supports bipartisan Health Tech Investment Act to expand Medicare reimbursement for FDA-approved AI medical devices, aiding innovation in mental health treatment.
Medicare Advantage Costs, Challenges, and Broker Roles: Insights from SCAN Health Plan CEO
Medicare Advantage increases federal spending but offers lower out-of-pocket costs for seniors. SCAN CEO Sachin Jain highlights program flaws, risk adjustment abuses, and broker roles.
Strategies to Reduce Medicare Out-of-Pocket Costs and Improve Care Access
Explore effective strategies for Medicare beneficiaries to reduce out-of-pocket healthcare costs, optimize insurance plans, and navigate coverage challenges in 2025.
Health Tech Investment Act Seeks to Expand Medicare AI Device Reimbursement
The Health Tech Investment Act proposes expanded Medicare reimbursement for FDA-approved AI medical devices, supported by Nexalin Technology to improve access and innovation in healthcare.
U.S. Pharmaceutical Regulation and Pricing: April 2025 Update
April 2025 update on U.S. pharmaceutical regulation highlights executive orders, budget changes, CMS policies, IRA litigation, and 340B program developments shaping drug pricing and access.
Senate Bill Proposes Clear Medicare Payment Pathway for AI Medical Devices
The Health Tech Investment Act aims to create a consistent Medicare payment system for FDA-approved AI medical devices, enhancing patient access and improving healthcare outcomes.
Dr. Oz sworn in as CMS administrator, Amid Focus on Medicare and Medicaid Reform
Dr. Mehmet Oz confirmed as CMS leader, emphasizing Medicare and Medicaid modernization, targeting fraud, and navigating potential Medicaid funding challenges amid federal budget pressures.
Regulatory Inspection Update: Holly Hill Mental Health Hospital Compliance with Medicare Standards
Holly Hill mental health hospital in North Carolina addresses CMS and NCDHHS compliance issues to maintain Medicare program eligibility. Follow-up inspection results pending.
Medicare Coverage for Anti-Obesity Drugs Gains Attention in Maine
Maine advocates seek Medicare coverage for anti-obesity medications to improve public health, reduce healthcare costs, and promote active transportation. Bipartisan support grows with Senator Susan Collins' leadership.
Trump Administration's Expansion of Executive Power Raises Constitutional Concerns
Analysis of the Trump administration's increased use of executive power, constitutional implications, impact on economic policy, and market stability risks.